These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16323473)

  • 1. [Achievements in morphological diagnosis of prostatic cancer: alpha-methylacyl-coenzyme-A-racemase--a new marker of malignant cell transformation].
    Pozharisskiĭ KM; Leenman EE; Arzumanov AA
    Arkh Patol; 2005; 67(5):15-9. PubMed ID: 16323473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
    Stewart J; Fleshner N; Cole H; Toi A; Sweet J
    J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.
    Carswell BM; Woda BA; Wang X; Li C; Dresser K; Jiang Z
    Histopathology; 2006 May; 48(6):668-73. PubMed ID: 16681682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.
    Sanderson SO; Sebo TJ; Murphy LM; Neumann R; Slezak J; Cheville JC
    Am J Clin Pathol; 2004 Feb; 121(2):220-5. PubMed ID: 14983935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
    Kunju LP; Chinnaiyan AM; Shah RB
    Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
    Jiang Z; Woda BA; Wu CL; Yang XJ
    Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
    Kaić G; Tomasović-Loncarić C
    Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
    Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
    Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of new prostate cancer markers: alpha methylacyl CoA racemase (P504S) and p63].
    Molinié V; Hervé JM; Lugagne PM; Yonneau L; Ellard S; Lebret T; Botto H
    Prog Urol; 2005 Sep; 15(4):611-5. PubMed ID: 16459672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of P504S (alpha-methylacyl-CoA racemase) in prostatic adenocarcinomas].
    Xiao Y; Chen J; Luo YF; Cao JL; Ling Q; Jin F
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1362-6. PubMed ID: 15387946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
    Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
    Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy.
    Suzue K; Montag AG; Tretiakova M; Yang XJ; Sahoo S
    Am J Clin Pathol; 2005 Apr; 123(4):553-61. PubMed ID: 15743746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
    Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
    Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-methylacyl coenzyme A racemase is immunoreactive in extramammary Paget disease.
    Mayes DC; Patterson JW; Ramnani DM; Mills SE
    Am J Clin Pathol; 2007 Apr; 127(4):567-71. PubMed ID: 17369131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy.
    Molinié V; Hervé JM; Lugagne PM; Lebret T; Botto H
    BJU Int; 2006 May; 97(5):1109-15. PubMed ID: 16643500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
    Stewart J; Fleshner N; Cole H; Sweet J
    J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
    Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
    Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.